Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Total Parenteral Nutrition-induced Cholestasis
Interventions
DRUG

Soybean oil (Standard treatment)

1\. Standard treatment: Soybean oil based emulsion: 0.25 g/kg/TPN day

DRUG

Soybean oil + Fish oil

Intralipid+Omegaven: 0.25 g/kg/TPN Intralipid day+0.4 g/kg/TPN Omegaven day for 6 months

Trial Locations (4)

T2N 4Z6

Foothills Medical Center, Calgary

T5H 3V9

University of Alberta, Edmonton

R2H 2A6

St Boniface Hospital, Winnipeg

M5G 2N2

University Health Network, Toronto

All Listed Sponsors
collaborator

ASPEN Rhoads Research Foundation

INDUSTRY

collaborator

Fresenius Kabi

INDUSTRY

collaborator

University of Alberta

OTHER

collaborator

Foothills Medical Centre

OTHER

collaborator

St. Boniface Hospital

OTHER

collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

St. Paul's Hospital, Canada

OTHER

lead

Johane Allard

OTHER